Across the European Union, tobacco control policy has long focused on reducing smoking prevalence through a combination of regulatory restrictions, public health campaigns, and excise taxation. These approaches have contributed to meaningful progress over time. However, smoking remains a leading cause of preventable disease, and reducing its impact continues to be a central objective of EU public health policy.
Within this broader European context, Sweden presents a distinct case. Over recent decades, Sweden has achieved one of the lowest smoking rates in the EU, alongside comparatively lower levels of smoking-related disease. This outcome has drawn increasing attention in policy discussions, particularly as the EU reviews key frameworks such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED).
A Different Public Health Outcome
Sweden’s experience reflects a significant shift in patterns of nicotine use. While cigarette smoking has declined, the use of non-combustible nicotine products has increased among adults. This transition has occurred within a regulatory environment that combines restrictions on smoking with the availability of alternative products.
From a public health perspective, the Swedish case is often examined in terms of outcomes. Lower smoking prevalence is associated with reductions in smoking-related disease, including conditions linked to long-term exposure to combustion-related toxins.
This outcome has led to growing interest in how different regulatory approaches may influence behaviour and whether elements of the Swedish experience may offer insights for broader EU policy.
Policy, Behaviour, and Outcomes
Public health policy is frequently shaped through legislative processes that involve negotiation, compromise, and institutional priorities. While these processes are essential for developing coherent regulatory frameworks, they do not always fully reflect how individuals respond to policy in real-world settings.
Johan Nissinen, former Member of the European Parliament and now working with the Global Institute for Novel Nicotine (GINN), has reflected on this distinction in the context of EU tobacco policy debates.
“After years of discussions in the European Parliament, it often felt that the focus was on language and positioning rather than on what actually changes behaviour,” Nissinen noted in conversations with GINN.
This observation highlights a broader challenge in public health policymaking: ensuring that regulatory frameworks are aligned not only with policy objectives but also with the ways in which individuals make decisions about their health.
Understanding the Swedish Experience
Sweden’s relatively low smoking rate did not emerge from a single policy measure. Rather, it reflects a combination of factors, including regulatory frameworks, cultural patterns, and the availability of alternatives to smoking.
One key feature of this environment is that adult smokers have had access to alternative nicotine products that do not involve combustion. While these products are not risk-free, scientific discussions increasingly recognise that they may present different risk profiles compared to cigarettes.
For some individuals, the availability of such alternatives appears to have contributed to a gradual shift away from smoking. This aligns with broader behavioural research suggesting that change often occurs incrementally rather than through immediate cessation.
Nissinen emphasised that this type of transition reflects practical realities rather than theoretical models of behaviour.
“What stands out in Sweden is that the shift away from cigarettes did not happen by accident,” he explained. “It reflects a system where people were given realistic ways to change, rather than being limited to a single outcome.”
Harm Reduction in a Public Health Context
The concept of harm reduction has been applied in various areas of public health, including substance use, infectious disease prevention, and injury reduction. In the context of tobacco control, harm reduction discussions focus on reducing exposure to the most harmful forms of nicotine consumption, particularly combustible tobacco.
Importantly, harm reduction does not imply that products are safe or that nicotine use is without risk. Instead, it reflects an approach that seeks to reduce overall harm in situations where eliminating risk entirely may not be immediately achievable for all individuals.
Within EU policy discussions, harm reduction remains a subject of debate. Policymakers must balance considerations such as youth protection, product safety, and long-term public health outcomes.
Evaluating Policy Through Outcomes
One of the key questions raised by the Swedish case is how public health policies should be evaluated. Traditional approaches often focus on regulatory inputs—such as the strength of restrictions or the scope of legislation. However, outcomes such as reductions in smoking prevalence and disease burden provide an additional lens through which policy effectiveness can be assessed.
Nissinen framed this issue in terms of outcomes versus intentions.
“Harm reduction is not about promoting nicotine,” he noted. “It is about reducing disease and mortality where harm already exists. Public health should ultimately be judged by its outcomes.”
This perspective aligns with broader principles of evidence-based policymaking, where the effectiveness of interventions is assessed based on measurable results.
Implications for EU Policy
As the European Union reviews the Tobacco Products Directive and the Tobacco Excise Directive, the Swedish experience is likely to remain part of ongoing policy discussions.
While regulatory approaches must reflect the diversity of Member States and maintain strong protections for young people, there may be value in examining how different policy environments influence behaviour and outcomes.
Understanding how and why smoking rates have declined in certain contexts can help inform future regulatory design. This includes considering how product regulation, taxation, and public health messaging interact to shape individual decisions.
Looking Ahead
The reduction of smoking-related harm remains a central goal of European public health policy. Achieving this objective requires regulatory frameworks that are both evidence-based and responsive to real-world behaviour.
Sweden’s experience provides one example of how changes in patterns of nicotine use can contribute to lower smoking prevalence and improved health outcomes. While no single model can be applied uniformly across all Member States, examining such cases may offer valuable insights for policymakers.
As discussions around the TPD and TED continue, the broader question remains: how can policy frameworks best support measurable improvements in public health?
In this context, focusing on outcomes, rather than intentions alone, may play an important role in shaping the next phase of EU tobacco and nicotine regulation.
